Employers Would ‘Welcome’ Government Role In Covering High-Cost Therapies

Annual large employer health benefits survey for 2020 and beyond finds support for government price negotiation and payment through a national fund. Plans to expand point-of-sale rebates and coupon accumulator programs also reported.

Government Intervention
Many Employers Think Treatments Need Deeper Pockets For Coverage

Nearly half of large US employers in a recent survey expressed support for government involvement in managing the cost of very expensive therapies on behalf of their employees.

The finding, which represents a shift in attitude, reflects “mounting apprehension” about managing the cost of cell and gene therapies...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet